Tobramycin Inhalation Powder Is Effective and Safe in the Treatment of Chronic Pulmonary Pseudomonas aeruginosa (Pa) Infection in Patients with Cystic Fibrosis

被引：0
|
作者：
Konstan, M. W. [1 ]
Geller, D. E. [2 ]
Brockhaus, F. [3 ]
Zhang, J. [3 ]
Angyalosi, G. [3 ]
机构：
[1] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA
[2] Nemours Childrens Clin, Orlando, FL USA
[3] Novartis, Basel, Switzerland
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1186
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] Economic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis
    Srilekha Panguluri
    Praveen Gunda
    Laurie Debonnett
    Kamal Hamed
    Clinical Drug Investigation, 2017, 37 : 795 - 805
  • [2] Economic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis
    Panguluri, Srilekha
    Gunda, Praveen
    Debonnett, Laurie
    Hamed, Kamal
    CLINICAL DRUG INVESTIGATION, 2017, 37 (08) : 795 - 805
  • [3] Tobramycin Inhalation Powder: A Review of Its Use in the Treatment of Chronic Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis
    McKeage, Kate
    DRUGS, 2013, 73 (16) : 1815 - 1827
  • [4] Tobramycin Inhalation Powder: A Review of Its Use in the Treatment of Chronic Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis
    Kate McKeage
    Drugs, 2013, 73 : 1815 - 1827
  • [5] Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence
    Hamed, Kamal
    Debonnett, Laurie
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2017, 11 (05) : 193 - 209
  • [6] Treatment compliance in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection treated with tobramycin inhalation powder: The FREE study
    Blasi, Francesco
    Carnovale, Vincenzo
    Cimino, Giuseppe
    Lucidi, Vincenzina
    Salvatore, Donatello
    Messore, Barbara
    Bartezaghi, Marta
    Muscianisi, Elisa
    Porpiglia, Pasquale Alberto
    RESPIRATORY MEDICINE, 2018, 138 : 88 - 94
  • [7] Tobramycin Inhalation Powder (TIP): An Efficient Treatment Strategy for the Management of Chronic Pseudomonas Aeruginosa Infection in Cystic Fibrosis
    Lam, John
    Vaughan, Steven
    Parkins, Michael D.
    CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2013, 7 : 61 - 77
  • [8] Tobramycin inhalation powder: an efficient and efficacious therapy for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis
    Somayaji, Ranjani
    Parkins, Michael D.
    THERAPEUTIC DELIVERY, 2015, 6 (02) : 121 - 137
  • [9] Eradication of Pseudomonas aeruginosa in cystic fibrosis patients with inhalation of dry powder tobramycin
    Akkerman-Nijland, Anne M.
    Yousofi, Mina
    Rottier, Bart L.
    Van der Vaart, Hester
    Burgerhof, Johannes G. M.
    Frijlink, Henderik W.
    Touw, Daan J.
    Koppelman, Gerard H.
    Akkerman, Onno W.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2020, 14
  • [10] BUDGET IMPACT ANALYSIS OF THE USE OF TOBRAMYCIN INHALATION POWDER (TIP) FOR THE TREATMENT OF CHRONIC PSEUDOMONAS AERUGINOSA (PA) INFECTION IN PATIENTS WITH CYSTIC FIBROSIS AGED ≥ 6 YEARS IN MEXICO
    Lemus, A.
    Rosas, J.
    VALUE IN HEALTH, 2013, 16 (03) : A72 - A72
12345